Boardroom Alpha
10-K primary document
INCY · Annual Report (Form 10-K) · Filed February 10, 2026

Incyte Corp10-K exhibit

exhibit211-12312025.htm
Document

Exhibit 21.1
SUBSIDIARIES
SubsidiaryJurisdiction of Incorporation
Escient Pharmaceuticals, Inc.
Delaware
Escient Pharmaceuticals Australia Pty Ltd
Australia
Incyte Holdings Corporation
Delaware
Incyte Real Estate Holdings I LLC
Delaware
Incyte Real Estate Holdings II LLC
Delaware
Incyte Research Institute LLC
Delaware
Villaris Therapeutics Inc.
Delaware
Incyte International Holdings Corporation
Delaware
Incyte Biosciences Canada Corporation
Canada
Incyte International Holdings S.à r.l.
Luxembourg
Incyte Biosciences International S.à r.l.
Switzerland
Incyte Biosciences Austria GmbH
Austria
Incyte Biosciences Denmark ApS
Denmark
Incyte Biosciences Finland Oy
Finland
Incyte Biosciences France
France
Incyte Biosciences Germany GmbH
Germany
Incyte Biosciences Italy S.R.L.
Italy
Incyte Biosciences Distribution B.V.
Netherlands
Incyte Biosciences Benelux B.V.
Netherlands
Incyte Biosciences Norway AS
Norway
Incyte Biosciences Iberia S.L.
Spain
Incyte Biosciences Nordic AB
Sweden
Incyte Biosciences Poland sp. z o.o.
Poland
Incyte Biosciences UK Ltd
UK
Incyte Biosciences Technical Operations S.à r.l.
Switzerland
Incyte Biosciences Australia Pty Ltd
Australia
Incyte Biosciences Japan G.K.
Japan
Incyte Biosciences (Shanghai) Co., Ltd.
China
Jidochem S.à r.l.
Switzerland


Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer